KEAP1 and skin basal cell carcinoma: Other data from Agyeman et al. suggested that NRF2 activation in MCF-10 and MCF-7 BCC due to KEAP1 silencing or treatment with SFN caused the transactivation of the enzyme glutaminase [51].